Cancer cost high in Germany

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.551, 2008-01, pp. : 2-2

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

High cost of dalteparin not worth added benefits in cancer

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 476, 2005-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Barriers to the uptake of new high-cost cancer drugs

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 605, 2010-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Adding Folinic Acid to Fluorouracil Plus Levamisole as Adjuvant Chemotherapy in Patients with Colon Cancer in Germany

By Monz B.U.M.

PharmacoEconomics, Vol. 21, Iss. 10, 2003-01 ,pp. : 709-719

Adis International

Access to resources Recommend Favorite

Pertussis vaccination potentially cost saving in Germany

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 558, 2008-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

Paediatric varicella vaccination cost saving in Germany

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 412, 2003-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite